Page 422 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

400 PART IV Specific Malignancies in the Small Animal Patient

114. Thamm DH, Turek MM, Vail DM: Outcome and prognostic fac- 137. Bookbinder PF, Butt MT, Harvey HJ: Determination of the number
tors following adjuvant prednisone/vinblastine chemotherapy for of mast cells in lymph node, bone marrow, and buffy coat cytologic
high-risk canine mast cell tumour: 61 cases, J Vet Med Sci 68:581– specimens from dogs, J Am Vet Med Assoc 200:1648–1650, 1992.
VetBooks.ir 115. Gieger TL, Theon AP, Werner JA, et al.: Biologic behavior and 138. Weishaar KM, Thamm DH, Worley DR, et al.: Correlation
587, 2006.
of nodal mast cells with clinical outcome in dogs with mast cell
prognostic factors for mast cell tumors of the canine muzzle: 24
node metastasis, J Comp Pathol 151:329–338, 2014.
cases (1990-2001), J Vet Intern Med 17:687–692, 2003. tumour and a proposed classification system for the evaluation of
116. Fife M, Blocker T, Fife T, et al.: Canine conjunctival mast cell 139. Sato AF, Solano M: Ultrasonographic findings in abdominal mast
tumors: a retrospective study, Vet Ophthalmol 14:153–160, 2011. cell disease: a retrospective study of 19 patients, Vet Radiol Ultra-
117. Krick EL, Billings AP, Shofer FS, et al.: Cytological lymph node sound 45:51–57, 2004.
evaluation in dogs with mast cell tumours: association with grade 140. Stefanello D, Valenti P, Faverzani S, et al.: Ultrasound-guided
and survival, Vet Comp Oncol 7:130–138, 2009. cytology of spleen and liver: a prognostic tool in canine cutaneous
118. Horta RS, Lavalle GE, Monteiro LN, et al.: Assessment of canine mast cell tumor, J Vet Intern Med 23:1051–1057, 2009.
mast cell tumor mortality risk based on clinical, histologic, immu- 141. Book AP, Fidel J, Wills T, et al.: Correlation of ultrasound find-
nohistochemical, and molecular features, Vet Pathol 55:212–223, ings, liver and spleen cytology, and prognosis in the clinical staging
2018. of high metastatic risk canine mast cell tumors, Vet Radiol Ultra-
119. Murphy S, Sparkes AH, Blunden AS, et al.: Effects of stage and sound 52:548–554, 2011.
number of tumours on prognosis of dogs with cutaneous mast cell 142. Hahn KA, Lantz GC, Salisbury SK: Comparison of survey radiog-
tumours, Vet Rec 158:287–291, 2006. raphy with ultrasonography and X-ray computed tomography for
120. Thamm DH, Mauldin EA, Vail DM: Prednisone and vinblastine clinical staging of subcutaneous neoplasms in dogs, J Am Vet Med
chemotherapy for canine mast cell tumor—41 cases (1992-1997), Assoc 196:1795–1798, 1990.
J Vet Intern Med 13:491–497, 1999. 143. Cayatte SM, McManus PM, Miller WH, et al.: Identification of
121. Kiupel M, Webster JD, Miller RA, et al.: Impact of tumour depth, mast cells in buffy coat preparations from dogs with inflammatory
tumour location and multiple synchronous masses on the prog- skin diseases, J Am Vet Med Assoc 206:325–326, 1995.
nosis of canine cutaneous mast cell tumours, J Vet Med A Physiol 144. McManus PM: Frequency and severity of mastocytemia in dogs
Pathol Clin Med 52:280–286, 2005. with and without mast cell tumors: 120 cases (1995-1997), J Am
122. Zavodovskaya R, Chien MB, London CA: Use of kit internal tan- Vet Med Assoc 215:355–357, 1999.
dem duplications to establish mast cell tumor clonality in 2 dogs, 145. Stockham SL, Basel DL, Schmidt DA: Mastocytemia in dogs with
J Vet Intern Med 18:915–917, 2004. acute inflammatory diseases, Vet Clin Pathol 15:16–21, 1986.
123. LaDue T, Price GS, Dodge R, et al.: Radiation therapy for incom- 146. Endicott MM, Charney SC, McKnight JA, et al.: Clinicopatho-
pletely resected canine mast cell tumors, Vet Radiol Ultrasound logical findings and results of bone marrow aspiration in dogs with
39:57–62, 1998. cutaneous mast cell tumours: 157 cases (1999-2002), Vet Comp
124. Chaffin K, Thrall DE: Results of radiation therapy in 19 dogs with Oncol 5:31–37, 2007.
cutaneous mast cell tumor and regional lymph node metastasis, Vet 147. Plier ML, MacWilliams PS: Systemic mastocytosis and mast cell
Radiol Ultrasound 43:392–395, 2002. leukemia. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s vet-
125. Camps-Palau MA, Leibman NF, Elmslie R, et al.: Treatment of erinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams
canine mast cell tumours with vinblastine, cyclophosphamide and & Wilkins, pp 747–754.
prednisone: 35 cases (1997-2004), Vet Comp Oncol 5:156–167, 148. Hikasa Y, Morita T, Futaoka Y, et al.: Connective tissue-type mast
2007. cell leukemia in a dog, J Vet Med Sci 62:187–190, 2000.
126. Mochizuki H, Motsinger-Reif A, Bettini C, et al.: Association of 149. Simpson AM, Ludwig LL, Newman SJ, et al.: Evaluation of surgi-
breed and histopathological grade in canine mast cell tumours, Vet cal margins required for complete excision of cutaneous mast cell
Comp Oncol 15:829–839, 2017. tumors in dogs, J Am Vet Med Assoc 224:236–240, 2004.
127. Pollack MJ, Flanders JA, Johnson RC: Disseminated malignant 150. Fulcher RP, Ludwig LL, Bergman PJ, et al.: Evaluation of a two-centi-
mastocytoma in a dog, J Am Anim Hosp Assoc 27:435–440, 1991. meter lateral surgical margin for excision of grade I and grade II cutane-
128. O’Keefe DA: Canine mast cell tumors, Vet Clin North Amer - Sm ous mast cell tumors in dogs, J Am Vet Med Assoc 228:210–215, 2006.
Anim Pract 20:1105–1115, 1990. 151. Pratschke KM, Atherton MJ, Sillito JA, et al.: Evaluation of a
129. Horta RDS, Giuliano A, Lavalle GE, et al.: Clinical, histological, modified proportional margins approach for surgical resection of
immunohistochemical and genetic factors associated with measur- mast cell tumors in dogs: 40 cases (2008-2012), J Am Vet Med Assoc
able response of high-risk canine mast cell tumours to tyrosine 243:1436–1441, 2013.
kinase inhibitors, Oncol Lett 15:129–136, 2018. 152. Johnson RE, Sigman JD, Funk GF, et al.: Quantification of surgi-
130. Clinkenbeard KD: Diagnostic cytology: mast cell tumors, Comp cal margin shrinkage in the oral cavity, Head Neck 19:281–286,
Cont Ed Pract Vet 13:1697–1704, 1991. 1997.
131. Mederle O, Mederle N, Bocan EV, et al.: VEGF expression in dog 153. Kerns MJ, Darst MA, Olsen TG, et al.: Shrinkage of cutaneous
mastocytoma, Rev Med Chir Soc Med Nat Iasi 114:185–188, 2010. specimens: formalin or other factors involved? J Cutan Pathol
132. Rabanal RH, Fondevila DM, Montane V, et al.: Immunocyto- 35:1093–1096, 2008.
chemical diagnosis of skin tumours of the dog with special refer- 154. Reimer SB, Seguin B, DeCock HE, et al.: Evaluation of the effect
ence to undifferentiated types, Res Vet Sci 47:129–133, 1989. of routine histologic processing on the size of skin samples obtained
133. Sandusky GE, Carlton WW, Wightman KA: Diagnostic immu- from dogs, Am J Vet Res 66:500–505, 2005.
nohistochemistry of canine round cell tumors, Vet Pathol 24:495– 155. Shaw T, Kudnig ST, Firestone SM: Diagnostic accuracy of pre-
499, 1987. treatment biopsy for grading cutaneous mast cell tumours in dogs,
134. Camus MS, Priest HL, Koehler JW, et al.: Cytologic criteria for Vet Comp Oncol 16:214–219, 2018.
mast cell tumor grading in dogs with evaluation of clinical out- 156. Prpich CY, Santamaria AC, Simcock JO, et al.: Second intention
come, Vet Pathol 53:1117–1123, 2016. healing after wide local excision of soft tissue sarcomas in the distal
135. Hergt F, von Bomhard W, Kent MS, et al.: Use of a 2-tier his- aspects of the limbs in dogs: 31 cases (2005-2012), J Am Vet Med
tologic grading system for canine cutaneous mast cell tumors on Assoc 244:187–194, 2014.
cytology specimens, Vet Clin Pathol 45:477–483, 2016. 157. al-Sarraf R, Mauldin GN, Patnaik AK, et al.: A prospective study
136. Scarpa F, Sabattini S, Bettini G: Cytological grading of canine of radiation therapy for the treatment of grade 2 mast cell tumors
cutaneous mast cell tumours, Vet Comp Oncol 14:245–251, 2016. in 32 dogs, J Vet Intern Med 10:376–378, 1996.